Publié le Jeudi 28 Mars 2024 14:48
Adrien Laroche of Dr André Pélegrin's team will defend his PhD thesis on "A novel type of bispecific antibody with targeted depletion activity of soluble pro-tumoral factors in the tumor microenvironment for cancer therapy" This Wednesday 3 December at 14:00, IRCM seminar room